Additionally, while promising, the long-term effects of CJC 1295 require further research and exploration
Long-term success requires thorough support including laboratory monitoring, dose adjustments, lifestyle improvement, and side effect management
Retatrutide is currently the most effective drug ever tested for weight loss, based on the latest clinical trial data
AOD 9604's clinical trial data reported it to be generally well tolerated with no significant adverse endocrine effects, consistent with its lack of IGF-1 stimulation
This has led to research interest in whether stimulating GH production through physiological rather than exogenous means could restore some of these functions
Research Classification: The CJC-1295 (NO DAC) + Ipamorelin blend is available exclusively for laboratory research use by qualified investigators